John Maraganore and Clive Meanwell are coming out of stealth

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/44/76/6a/44766a4c-7495-de55-f956-98bf47a79da4/mza_7129400420082630014.jpg/600x600bb.jpg

Post-Hoc Live

Endpoints News

28 episodes

6 days ago

Post-Hoc Live is an extension of Endpoints' analysis newsletter Post-Hoc — but streamed live on YouTube then brought to you here. Our reporters spend every day texting and calling sources, reading executive orders, and talking to each other in Slack. We're bringing that analysis that happens behind the scenes directly to you, and letting you in on some of our up-to-the-moment conversations. Subscribe to Endpoints and the Post-Hoc newsletter here: https://profile.endpoints.news/create-account. Send us an email at: posthoclive@endpointsnews.com

News

RSS

All content for Post-Hoc Live is the property of Endpoints News and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

News

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43803961/43803961-1748957343158-e4d9415936a7a.jpg

John Maraganore and Clive Meanwell are coming out of stealth

Post-Hoc Live

38 minutes 1 second

2 months ago

John Maraganore and Clive Meanwell are coming out of stealth

John Maraganore and Clive Meanwell are teaming up again. The two biotech luminaries are coming out of stealth today as co-CEOs of Corsera Health, and have plans to create a two-RNAi drug for cardiovascular disease prevention. They’re joining Post-Hoc Live today to talk about why they’re betting their own money on the venture, their approach to starting companies, and what they think is coming next for the industry.